6.1
The Appraisal Committee considered that further research into the effectiveness of anti-VEGFs in wet AMD could include studies:
-
about the cost effectiveness of ranibizumab compared with bevacizumab
-
to investigate the long-term effects of anti-VEGFs in patients with AMD, including effects on visual acuity, anatomical damage to the macula, quality of life and adverse events
-
to establish the appropriate duration and optimal treatment regimen in terms of frequency of injections.